Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | CASP1 | P29466 | 1/20 | 0.30 |
| ▸ | CASP7 | P55210 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18385549 | 1.00 | KDM4E (0.30) | KDM4EALDH1A1HPGDTSHRMAPK1 | |
| SCHEMBL18385566 | 1.00 | KDM4E (0.30) | KDM4EALDH1A1HPGDTSHRMAPK1 | |
| SCHEMBL18385542 | 0.97 | KDM4E (0.31) | KDM4EALDH1A1HPGDTSHRMAPK1 | |
| SCHEMBL18385435 | 0.97 | KDM4E (0.31) | KDM4EALDH1A1HPGDTSHRMAPK1 | |
| SCHEMBL18385444 | 0.97 | KDM4E (0.31) | KDM4EALDH1A1HPGDTSHRMAPK1 | |
| SCHEMBL18385453 | 0.97 | KDM4E (0.31) | KDM4EALDH1A1HPGDTSHRMAPK1 | |
| SCHEMBL18385460 | 0.97 | KDM4E (0.31) | KDM4EALDH1A1HPGDTSHRMAPK1 | |
| SCHEMBL18385535 | 0.97 | KDM4E (0.31) | KDM4EALDH1A1HPGDTSHRMAPK1 | |
| SCHEMBL17879006 | 0.96 | KDM4E (0.33) | KDM4EALDH1A1HPGDTSHRMAPK1 | |
| SCHEMBL18385187 | 0.96 | NPY5R (0.30) | KDM4EALDH1A1HPGDTSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170018719-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2017-01-19 | — | — | US | disclosed |
| US-20170018719-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2017-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170018719-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | CD99, BMI1, ETV6 | KDM4E 255/4885ALDH1A1 601/4885HPGD 3186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.